KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Times Interest Earned (2018 - 2025)

Historic Times Interest Earned for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Q3 2025 value amounting to $27.07.

  • Aurinia Pharmaceuticals' Times Interest Earned rose 17830.39% to $27.07 in Q3 2025 from the same period last year, while for Sep 2025 it was $15.81, marking a year-over-year increase of 34169.7%. This contributed to the annual value of -$0.97 for FY2024, which is 9706.62% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' Times Interest Earned stood at $27.07, which was up 17830.39% from $17.98 recorded in Q2 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Times Interest Earned peaked at $160.32 during Q4 2021, and registered a low of -$248.77 during Q2 2023.
  • Over the past 4 years, Aurinia Pharmaceuticals' median Times Interest Earned value was -$1.26 (recorded in 2024), while the average stood at -$5.5.
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Times Interest Earned soared by 9357.07% in 2024 and then skyrocketed by 152361.75% in 2025.
  • Aurinia Pharmaceuticals' Times Interest Earned (Quarter) stood at $160.32 in 2021, then tumbled by 114.13% to -$22.65 in 2023, then skyrocketed by 93.57% to -$1.46 in 2024, then skyrocketed by 1958.42% to $27.07 in 2025.
  • Its last three reported values are $27.07 in Q3 2025, $17.98 for Q2 2025, and $20.48 during Q1 2025.